Foamlab Secures €3 Million in Growth Funding
Delft-based Foamlab, a company specializing in high-performance, bio-based foams made from bacterial cellulose, has successfully raised €3 million in a growth funding round. This investment aims to bolster the development of their innovative foam materials, which are designed to replace fossil-based plastics with a tunable, lightweight, and compostable alternative.
Investors and Funding Round Details
The funding round was led by ICOS Capital, with additional participation from Value Factory Ventures, DOEN Ventures, Capricorn Industrial Biotech Fund, and TTT Green Tech. This diverse group of investors underscores the growing interest in sustainable materials and the potential impact of Foamlab’s technology across various sectors.
Strategic Plans for the Funding
The newly acquired funds will be directed towards several key initiatives. Foamlab plans to construct a pilot plant to scale up the production of their bio-based foams. This step is crucial for meeting the increasing demand from industries such as construction, furniture, fashion, and packaging.
Foamlab is also focused on accelerating the commercialization of its materials. "We see growing demand for our bacterial nanocellulose foams across multiple industries," said Jeroen van Rotterdam, CEO of Foamlab. "This funding enables us to scale production, serve early customers, and accelerate our path to market. Beyond capital, our investors bring hands-on support and valuable networks."
Company Background
Founded by Professor Elvin Karana and Jeroen van Rotterdam, Foamlab utilizes microorganisms to create foams that are not only high-performing but also environmentally friendly. The company aims to replace traditional oil- and mineral-based foams, offering a sustainable alternative that aligns with increasing global efforts to reduce plastic waste.
Outlook
With this growth funding, Foamlab is well-positioned to expand its operations and reach new markets. The construction of the pilot plant will serve as a significant milestone in their journey towards large-scale production and wider adoption of their bio-based foams.
For more information about Foamlab and their products, visit their website.